title: [EXPERIMENTAL STUDY ON DIFFERENT CONCENTRATION RATIOS OF OSTEOPROTEGERIN COMBINED WITH DEPROTEINIZED BONE ON BONE TUNNEL AFTER ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION].
abstract: OBJECTIVE
  To investigate the effects of different concentrations of osteoprotegerin (OPG) combined with deproteinized bone (DPB) on the bone tunnel after the anterior cruciate ligament (ACL) reconstruction.
  
  
  METHODS
  The femoral epiphyseal side was harvested from newborn calf, and allogenic DPB were prepared by hydrogen peroxide-chloroform/methanol method. Then, DPB were immersed in 3 concentrations levels of OPG (30, 60, 100 µg/mL) and 3 concentration ratios (30%, 60%, 100%) of the gel complex were prepared. Sixty healthy New Zealand white rabbits, male or female, weighing (2.7 ± 0.4) kg, were divided randomly into 4 groups (n = 15): control group (group A), 30% (group B), 60% (group C), and 100% (group D) OPG/DPB gel complex. The ACL reconstruction models were established by autologous Achilles tendon. Different ratios of OPG/DPB gel complex were implanted in the femoral and tibial bone tunnel of groups B, C, and D, but group A was not treated. The pathology observation (including the percentage of the femoral bone tunnel enlargement) and histological observation were performed and the biomechanical properties were measured at 4, 8, and 12 weeks after operation.
  
  
  RESULTS
  One rabbit died of infection in groups A and D, 2 rabbits in groups B and C respectively, and were added. General pathology observation showed that the internal orifices of the femoral and tibia tunnels were covered by a little of scar tissue at 4 weeks in all groups. At 8 weeks, white chondroid tissues were observed around the internal orifices of the femoral and tibia tunnels, especially in groups C and D. At 12 weeks, the internal orifices of the femoral and tibia tunnels enlarged in groups A, B, and C, but it was completely closed in group D. At each time point, the rates of the femoral bone tunnel enlargement in groups B, C, and D were significantly lower than that in group A, and group D was significantly lower than groups B and C (P < 0.05); group C was significantly lower than group B at 8 weeks, but no significant difference was found at 4 and 12 weeks (P < 0.05). Hisological observation showed that fresh fibrous connective tissue was observed in 4 groups at 4 weeks; there was various arrangements of Sharpey fiber in all groups at 8 weeks and the atypical 4-layer structure of bone was seen in group D; at 12 weeks, Sharpey fiber arranged regularly in all groups, with typical 4-layer structure of bone in groups B, C, and D, and an irregular "tidal line" formed, especially in group D. Biomechanics measurement showed that the maximum tensile load in group D was significantly higher than that in groups A and B at 4 weeks (P < 0.05), but no significant difference was shown among groups A, B, and C, and between groups C and D (P > 0.05); at 8 weeks, it was significantly higher in groups C and group D than group A, and in group D than group B (P < 0.05), but there was no significant difference between groups A, C and group B (P > 0.05); at 12 weeks, it was significantly higher in groups C and D than groups A and B, and in group D than group C (P < 0.05), but difference was not significant between groups A and B (P > 0.05).
  
  
  CONCLUSIONS
  Different concentrations ratios of OPG/DPB gel complexes have different effects on the bone tunnel after ACL reconstruction. 100% OPG/DPB gel complex has significant effects to prevent the enlargement of bone tunnel and to enhance tendon bone healing.
authors.forename: Bing
authors.initials: B
authors.lastname: Wei
authors.forename: Guoyao
authors.initials: G
authors.lastname: Zou
authors.forename: Enhong
authors.initials: E
authors.lastname: Song
authors.forename: Lincong
authors.initials: L
authors.lastname: Guan
mesh_terms: D000125:Achilles Tendon / Q000601:surgery*; D000818:Animals; D016118:Anterior Cruciate Ligament / Q000601:surgery / Q000637:transplantation*; D059549:Anterior Cruciate Ligament Reconstruction / Q000379:methods*; D001842:Bone and Bones / Q000601:surgery*; D002417:Cattle; D005260:Female; D005269:Femur; D008297:Male; D053244:Osteoprotegerin; D011817:Rabbits; D013977:Tibia
chemical_list: D053244:Osteoprotegerin; C506030:TNFRSF11B protein, human